期刊文献+

肝组织工程的研究进展与展望 被引量:3

The Research and Prospect of Liver Tissue Engineering
暂未订购
导出
摘要 我国是世界上急性肝衰竭和终末性肝病发病人数最多的国家。目前,这两种疾病治疗的唯一有效手段是进行肝移植。但肝脏供体紧缺制约了移植手术的发展。组织工程学是解决肝脏生物制造最有效的方法,但是肝组织工程的发展依然需要克服一系列技术挑战,包括种子细胞种类、来源;支架材料性能和结构的要求;组织、器官体外培养和构建等方面等难题。我们相信随着科学技术的不断发展,在不久的将来,通过组织工程方法必将成功构造一个具有各种生理功能的可移植的肝脏。 China is the country which hold the highest incidence rate of acute and chronic liver disease. Liver transplantation is the only effective way for the disease. However, its clinical development is hampered by the shortage of organ supply. Tissue engineering appeares the most promising therapy for hver diseases. However, there are many technical challenges including the cell source, nontoxic and biocompatible material in vitro cultivation of the construct. With the fast development of technology, a functional tissue engineered liver capable of transplantation will be constructed successfully in the near future.
出处 《生物医学工程研究》 2009年第1期79-82,共4页 Journal Of Biomedical Engineering Research
关键词 组织工程 肝衰竭 肝脏移植 支架材料 生物反应器 生物人工肝 Tissue engineering Hepatic failure Liver transplantation Scaffold Bioreactor Biological artificial liver
  • 相关文献

参考文献20

  • 1Davis MW,Vacanti JP.Toward development of an implantable tissue-engineered liver[J].Biomaterials,1996,17(3):365 -372.
  • 2Allen JW,Bhatia SN.Engineering liver therapies for the future[J].Tissue Eng,2002,8(5):725 -737.
  • 3Willers C,Partsalis T,Zheng MH.Articular cartilage repair:procedures versus products[J].Expert Rev Med Devices,2007,4(3):373-92.
  • 4Clark RA,Ghosh K,Tonnesen MG.Tissue engineering for cutaneous wounds[J].J Invest Dermatol,2007,127(5):1018-1029.
  • 5Kaplan DL,Moon RT,Vunjak-Novakovic G.It takes a village to grow a tissu[J].Nat Biotechnol,2005,23(10):1237-1239.
  • 6Mitaka T,Mizuguchi T,Sato F,et al.Growth and maturation of small hepatocytes[J].J Gastroenterol Hepatol,1998,13(Suppl.):S70-S77.
  • 7Nyberg SL,Remmel RP,Mann HJ,et al.Primary hepatocytes outperform HepG2 cells as the source of biotransformation functions in a bioartificial liver[J].Ann Surg,1994,220(1):59-67.
  • 8Faris RA,Konkin T,Halpert G.Liver stem cells:a potentialsource of hepatocytes for the treatment of human liver disease[J].Artif Organs,2001,25(7):513-521.
  • 9Noishiki Y.Dreams for the future in the field of in vivo tissue engineering[J].Artif Organs,2001,25(3):159-163.
  • 10Gupta S,Malhi H,Gorla GR.Re-Engineering the liver with natural biomaterials[J].Yonsei Med J,2000,41(6):814-824.

同被引文献30

  • 1汪海滨,罗盛康.组织工程支架材料的研究现状[J].中国临床康复,2004,8(20):4063-4065. 被引量:6
  • 2李春峰,王韵.丝素蛋白应用于生物医学领域的研究进展[J].蚕学通讯,2005,25(4):16-18. 被引量:3
  • 3黄明华,陈庆华,刘美红,李自良.组织工程支架材料研究进展及发展趋势[J].材料导报,2006,20(F11):365-368. 被引量:8
  • 4KULIG K M,VACANTI J P.Hepatic tissue engineering[J].Transpl Immunol,2004,12(3-4):303-310.
  • 5CHUNG T W,YANG J,AKAIKE T,et al.Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment[J].Biomaterials,2002,23(14):2827-2834.
  • 6PALMES D,SPIEGEL H U.Animal models of liver regeneration[J].Biomaterials,2004,25(9):1601-1611.
  • 7LEE Y M,PARK Y J,LEE S J,et al.Tissue engineered bone formation using chitosan/tricalcium phosphate sponges[J].J Periodontol,2000,71(3):410-417.
  • 8WEI X,WANG C Y,LIU Q P,et al.In vitro hepatic differentiation of mesenchymal stem cells from human fetal bone marrow[J].J Int Med Res,2008,36 (4):721-727.
  • 9Unger R E,Wolf M,Peters K,et al.Growth of human cells on a non-woven silk fibroin net:A potential for use in tissue engineering[J].Biomaterials,2004,25 (6):1069.
  • 10刘利,万涛,李世普.半乳糖基化壳聚糖材料的合成与表征[J].武汉理工大学学报,2007,29(12):29-31. 被引量:4

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部